GlaxoSmithKline to supply HHS with 60,000 doses of raxibacumab, anthrax antitoxin
The US Department of Health and Human Services (HHS) has announced today the nation’s supply of anthrax antitoxin will be maintained until 2018 under Project BioShield contracts issued by the U.S. Department of More...